Campylobacter fetus infectious disease
disease diseaseOn this page
Also known as infection by Campylobacter fetusinfection by Campylobacter foetusinfection by vibrio foetusinfection caused by Campylobacter foetusinfection caused by vibrio foetus
Summary
Campylobacter fetus infectious disease (MONDO:0040728) is a disease. A subtype of campylobacteriosis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | Campylobacter fetus infectious disease |
| Mondo ID | MONDO:0040728 |
| SNOMED CT | 111835002 |
| UMLS | C0275979 |
| MedGen | 547000 |
| Is cancer (heuristic) | no |
Also known as: infection by Campylobacter fetus · infection by Campylobacter foetus · infection by vibrio foetus · infection caused by Campylobacter foetus · infection caused by vibrio foetus
Disease family
Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious disease › bacterial infectious disease › primary bacterial infectious disease › campylobacteriosis › Campylobacter fetus infectious disease
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.